Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW023W7Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7

✓ Valid for 2027

Short description: Introduce COVID19 Vacc Bstr in Muscle, Perc, New Tech 7

Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW023W7

XW023W7 is the ICD-10-PCS code for a introduction procedure on the muscle using a percutaneous approach with COVID-19 vaccine booster (qualifier: new technology group 7). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW013W7 (subcutaneous tissue).

With a different device, use XW023V7 (xanomeline and trospium chloride) and XW023Y7 (other new technology monoclonal antibody).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2022, effective October 1, 2021.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
2Muscle
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
WCOVID-19 Vaccine Booster
7. Qualifier
7New Technology Group 7

Other versions of this procedure

Different body part

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2022 (effective 10/1/2021): Added
  • No changes since FY2022.

Common questions about XW023W7

Is XW023W7 a valid ICD-10-PCS code for 2027?

Yes. XW023W7 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.